The FDA's risk aversion costs lives, but the Japanese process for drug approval offers a solution. Read more at The Hill [3].
Links[1] https://www.mercatus.org/external-people/diane-abbitt [2] https://www.mercatus.org/external-people/bartley-madden [3] https://thehill.com/opinion/healthcare/515145-seniors-suffer-the-most-from-antiquated-fda-approval-process
Seniors Suffer the Most From Antiquated FDA Approval Process
Diane Abbitt [1]
Bartley Madden [2]
The FDA's risk aversion costs lives, but the Japanese process for drug approval offers a solution. Read more at The Hill [3].